Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease — Stella

Home/Nontuberculous Mycobacterial Lung Disease/Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

View on ClinicalTrials.gov

Recruiting

Back to Nontuberculous Mycobacterial Lung Disease trials

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Netherlands

Radboud University Medical Center, Nijmegen

Key details

Phase

Post-approval study

Sponsor

Radboud University Medical Center

Enrollment target

~30 participants

Started

May 2022

Primary completion

October 2026

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.